Analysis of Recurrent Stroke Volume and Prognosis between Warfarin and Four Non–Vitamin K Antagonist Oral Anticoagulants’ Administration for Secondary Prevention of Stroke

By Yukie Kanai, Hiroaki Oguro, Nao Tahara, Hanako Matsuda, Hiroyuki Takayoshi, Shingo Mitaki, Keiichi Onoda, Shuhei Yamaguchi On Oct 21, 2017

We investigated recurrent stroke volume with nonvalvular atrial fibrillation (NVAF) patients treated with non–vitamin K antagonist oral anticoagulants (NOACs) about clinical backgrounds and number of recurrent stroke.